๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacologic management of cardiovascular problems in women

โœ Scribed by Lorna Davis; Peter Stecy


Publisher
Elsevier Science
Year
1997
Weight
950 KB
Volume
42
Category
Article
ISSN
0091-2182

No coin nor oath required. For personal study only.

โœฆ Synopsis


Cardiovascular disease is the leading cause of death among women in the United States. Nurse-midwives play a unique role in screening their clients, especially because they will be caring for an increasing number of aging women as the population grows older. Risk assessment, health history, physical examination, and nonpharmacologic management of cardiovascular problems in women are discussed in the March/April 1995 issue of the Journal of Nurse-Midwifery. This article presents an overview of the most common cardiac drugs that nurse-midwives may encounter in treating these women and provides guidelines for referring patients who require medical intervention. Common medications to treat hypertension, coronary artery disease, and hyperlipidemia are detailed; in addition, mechanisms of action, therapeutic indications, dosage, and adverse effects are listed in tables for easy reference.


๐Ÿ“œ SIMILAR VOLUMES


Pharmacologic management of common lower
โœ Steven Leiner; Mary Mays ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 128 KB

## ABSTRACT In a primary care setting, midwives collaboratively manage common lower respiratory conditions that require pharmacologic therapy. Current knowledge about the indications, use, adverse effects, and potential side effects of these medications is essential. This article reviews the drugs

Pharmacologic interventions for manageme
โœ O'Donnell, Maureen ;Armstrong, Robert ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 111 KB ๐Ÿ‘ 2 views

The management of the child or adult with spasticity associated with cerebral palsy may include a number of treatment techniques, including physical therapy, orthopedic surgery, neurosurgery, and pharmacologic management. The purpose of this review is to provide a framework in which the pharmacologi

Cardiovascular pharmacology of 3-n -buty
โœ D. Tsi; B. K. H. Tan ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 144 KB ๐Ÿ‘ 2 views

The hypotensive and vasorelaxant effects of 3-n-butylphthalide (BuPh) and its possible mechanisms of action were investigated in spontaneously hypertensive rats (SHR) for the first time. A 13-day intraperitoneal infusion of BuPh at doses of 2.0 and 4.0 mg/day produced a transient hypotensive effect